ENTITY
Celltrion

Celltrion (068270 KP)

22
Analysis
Health CareSouth Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
05 Oct 2016 12:01

Samsung BioLogics IPO Part 3 - Valuation

Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...

Logo
335 Views
Share
04 Oct 2016 07:43

Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue

In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise ₩1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans...

Logo
279 Views
Share
04 Oct 2016 03:57

Korea Stock Market Monthly Recap #6 - (September 2016)

The six major events in the Korea Stock Market in September were as follows: LG Chem-LG Life Sciences merger, Hanjin Shipping applying for court...

Logo
167 Views
Share
17 Sep 2016 22:47

Korea's Foreign Direct Investment Trend

LS Cable & System Asia Ltd (229640 KS) and Hwaseung Enterprise Co. are two Vietnam related stocks that will be listed on the Korea Stock Market...

Logo
183 Views
Share
bearishCelltrion Inc
16 Sep 2016 06:18

More Harsh Reality from Teva

U.S. healthcare industry leaders from across the spectrum of industry segments continue to downplay the near-term adoption of biosimilars in the...

Share
x